Top

Published in:

01-09-2009 | Case Report

Tuberculous myositis in a patient with ankylosing spondylitis treated with adalimumab

Authors: Valdeŕilio Feijó Azevedo, C. Parchen, S. A. Coelho, D. C. Lacerda, C. G. Hirth

Published in: Rheumatology International | Issue 11/2009

Abstract

We present a rare case of tuberculous myositis in a 36-year-old man with long-standing ankylosing spondyltis treated with adalimumab. We review the association between antitumor necrosis factor therapy and tuberculous myositis. Our case illustrates that the index of suspicion of tuberculosis in these patients, even with atypical clinical features, must be very high and emphasizes that this rare infection may occur even with negative tuberculosis screening before therapy was started.

Braun J, Landewe R, Hermann KG et al (2006) Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 54:1646–1652. doi:10.1002/art.21790 PubMedCrossRef

Davis JC Jr, van der Heijde D, Braun J et al (2003) Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48:3230–3236. doi:10.1002/art.11325 PubMedCrossRef

van der Heijde D, Kivitz A, Schiff MH et al (2006) Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 54:2136–2146. doi:10.1002/art.21913 PubMedCrossRef

Zochling J, van der Heijde D, Burgos-Vargas R et al (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442–452. doi:10.1136/ard.2005.041137 PubMedCrossRef

Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122–2127. doi:10.1002/art.11137 PubMedCrossRef

Sieper J, Rudwaleit M, Braun J (2007) Adalimumab for the treatment of ankylosing spondylitis. Expert Opin Pharmacother 8(6):831–838. doi:10.1517/14656566.8.6.831 PubMedCrossRef

Schiff MH, Burmester GR, Kent JD, Pangan AL, Kupper H, Fitzpatrick SB, Donovan C (2006) Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis. Ann Rheum Dis 65(7):889–894. doi:10.1136/ard.2005.043166 PubMedCrossRef

Rojas-Villarraga A, Agudelo CA, Pineda-Tamayo R, Porras A, Matute G, Anaya JM (2007) Tuberculosis in patients treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile? Biomedica (Bogota) 27(2):159–171

Enarson DA, Fujii M, Nakielna EM, Grzybowski S (1979) Bone and joint tuberculosis: a continuing problem. Can Med Assoc J 120:139–145PubMed

10.

Wang JY, Lee LN, Hsueh PR, Shih JY, Chang YL, Yang PC, Luh KT (2003) Tuberculous myositis: a rare but existing clinical entity. Rheumatology (Oxford) 42(7):836–840

11.

Puttick MPE, Stein HB, Chan RMT, Elwood RK, How AR, Reid GD (1995) Soft tissue tuberculosis: a series of 11 cases. J Rheumatol 22:1321–1325PubMed

12.

Gutiérrez-Macías A, Lizarralde-Palacios E, Martínez-Odriozola P, Miguel-de la Villa F (2007) Tuberculous peritonitis in a patient with rheumatoid arthritis treated with adalimumab. Clin Rheumatol 26(3):452–453. doi:10.1007/s10067-005-0164-3 PubMedCrossRef

13.

Efde MN, Houtman PM, Spoorenberg JP, Jansen TL (2005) Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab)treatment. Neth J Med 63(3):112–114PubMed

14.

Lertxundi U, Mayo J, García M, Ruiz B, Aguirre C (2005) Tuberculosis miliar tras tratamiento con adalimumab. Farm Hosp 29(5):343–347CrossRef

15.

Wang WY, Lin FC, Tsao TY, Lu JJ (2007) Tuberculous myositis: an unusual presentation of extrapulmonary tuberculosis. J Microbiol Immunol Infect 40(1):79–82PubMed

16.

Bonomo RA, Graham R, Makley JT, Petersilge CA (1995) Tuberculous pyomyositis: an unusual presentation of disseminated Mycobacterium tuberculosis infection. Clin Infect Dis 20:1576–1577PubMed

17.

FitzGerald R, Hutchinson CE (1992) Tuberculosis of the ribs: computed tomographic findings. Br J Radiol 65:822–824PubMedCrossRef

18.

Johnson DW, Herzig KA (2000) Isolated tuberculous pyomyositis in a renal transplant patient. Nephrol Dial Transplant 15:743. doi:10.1093/ndt/15.5.743 PubMedCrossRef

19.

Gahlaut DS, Kedav N, Sikka KK, Singh KN, Samuel KC (1973) Generalised skeletal muscle tuberculosis. J Indian Med Assoc 61:92–93PubMed

Title: Tuberculous myositis in a patient with ankylosing spondylitis treated with adalimumab
Authors: Valdeŕilio Feijó Azevedo
C. Parchen
S. A. Coelho
D. C. Lacerda
C. G. Hirth
Publication date: 01-09-2009
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 11/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-008-0837-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Tuberculous myositis in a patient with ankylosing spondylitis treated with adalimumab

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2009

The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports

Dermatomyositis with hemorrhagic myositis

Silicone-induced foreign-body reaction after first metatarsophalangeal joint arthroplasty for Jaccoud’s arthropathy

An unusual central nervous system involvement in rheumatoid arthritis: combination of pachymeningitis and cerebral vasculitis

Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation

Increased frequency of familial Mediterranean fever in northern Turkey: a population-based study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page